These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 32468494

  • 1. Behavioral and Molecular Basis of Cholinergic Modulation of Pain: Focus on Nicotinic Acetylcholine Receptors.
    Toma W, Ulker E, Alqasem M, AlSharari SD, McIntosh JM, Damaj MI.
    Curr Top Behav Neurosci; 2020; 45():153-166. PubMed ID: 32468494
    [Abstract] [Full Text] [Related]

  • 2. Allosteric modulation of α4β2* nicotinic acetylcholine receptors: Desformylflustrabromine potentiates antiallodynic response of nicotine in a mouse model of neuropathic pain.
    Bagdas D, Ergun D, Jackson A, Toma W, Schulte MK, Damaj MI.
    Eur J Pain; 2018 Jan; 22(1):84-93. PubMed ID: 28809075
    [Abstract] [Full Text] [Related]

  • 3. α4β2* neuronal nicotinic receptor ligands (agonist, partial agonist and positive allosteric modulators) as therapeutic prospects for pain.
    Nirogi R, Goura V, Abraham R, Jayarajan P.
    Eur J Pharmacol; 2013 Jul 15; 712(1-3):22-9. PubMed ID: 23660369
    [Abstract] [Full Text] [Related]

  • 4. Modeling subtype-selective agonists binding with alpha4beta2 and alpha7 nicotinic acetylcholine receptors: effects of local binding and long-range electrostatic interactions.
    Huang X, Zheng F, Chen X, Crooks PA, Dwoskin LP, Zhan CG.
    J Med Chem; 2006 Dec 28; 49(26):7661-74. PubMed ID: 17181149
    [Abstract] [Full Text] [Related]

  • 5. Effects of neuronal nicotinic acetylcholine receptor allosteric modulators in animal behavior studies.
    Pandya AA, Yakel JL.
    Biochem Pharmacol; 2013 Oct 15; 86(8):1054-62. PubMed ID: 23732296
    [Abstract] [Full Text] [Related]

  • 6. Small molecule ligands for α9 * and α7 nicotinic receptors: A survey and an update, respectively.
    Giraudo A, Pallavicini M, Bolchi C.
    Pharmacol Res; 2023 Jul 15; 193():106801. PubMed ID: 37236412
    [Abstract] [Full Text] [Related]

  • 7. Targeting α4β2 nicotinic acetylcholine receptors in central nervous system disorders: perspectives on positive allosteric modulation as a therapeutic approach.
    Grupe M, Grunnet M, Bastlund JF, Jensen AA.
    Basic Clin Pharmacol Toxicol; 2015 Mar 15; 116(3):187-200. PubMed ID: 25441336
    [Abstract] [Full Text] [Related]

  • 8. Procognitive effects of varenicline in the animal model of schizophrenia depend on α4β2- and α 7-nicotinic acetylcholine receptors.
    Potasiewicz A, Golebiowska J, Popik P, Nikiforuk A.
    J Psychopharmacol; 2018 Dec 03; 33(1):269881118812097. PubMed ID: 30501536
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Advances in the In vitro and In vivo pharmacology of Alpha4beta2 nicotinic receptor positive allosteric modulators.
    Wilkerson JL, Deba F, Crowley ML, Hamouda AK, McMahon LR.
    Neuropharmacology; 2020 May 15; 168():108008. PubMed ID: 32113032
    [Abstract] [Full Text] [Related]

  • 12. Sazetidine-A, a novel ligand that desensitizes alpha4beta2 nicotinic acetylcholine receptors without activating them.
    Xiao Y, Fan H, Musachio JL, Wei ZL, Chellappan SK, Kozikowski AP, Kellar KJ.
    Mol Pharmacol; 2006 Oct 15; 70(4):1454-60. PubMed ID: 16857741
    [Abstract] [Full Text] [Related]

  • 13. A silent agonist of α7 nicotinic acetylcholine receptors modulates inflammation ex vivo and attenuates EAE.
    Godin JR, Roy P, Quadri M, Bagdas D, Toma W, Narendrula-Kotha R, Kishta OA, Damaj MI, Horenstein NA, Papke RL, Simard AR.
    Brain Behav Immun; 2020 Jul 15; 87():286-300. PubMed ID: 31874200
    [Abstract] [Full Text] [Related]

  • 14. Nicotinic acetylcholine receptors: Therapeutic targets for novel ligands to treat pain and inflammation.
    Hone AJ, McIntosh JM.
    Pharmacol Res; 2023 Apr 15; 190():106715. PubMed ID: 36868367
    [Abstract] [Full Text] [Related]

  • 15. Review: The nicotinic modulation of pain.
    Bektas N, Nemutlu D, Cam M, Okcay Y, Eken H, Arslan R.
    Pak J Pharm Sci; 2020 Jan 15; 33(1):229-239. PubMed ID: 32122853
    [Abstract] [Full Text] [Related]

  • 16. DM506 (3-Methyl-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole fumarate), a Novel Derivative of Ibogamine, Inhibits α7 and α9α10 Nicotinic Acetylcholine Receptors by Different Allosteric Mechanisms.
    Tae HS, Ortells MO, Tekarli BJ, Manetti D, Romanelli MN, McIntosh JM, Adams DJ, Arias HR.
    ACS Chem Neurosci; 2023 Jul 19; 14(14):2537-2547. PubMed ID: 37386821
    [Abstract] [Full Text] [Related]

  • 17. New Insights on Neuronal Nicotinic Acetylcholine Receptors as Targets for Pain and Inflammation: A Focus on α7 nAChRs.
    Bagdas D, Gurun MS, Flood P, Papke RL, Damaj MI.
    Curr Neuropharmacol; 2018 Jul 19; 16(4):415-425. PubMed ID: 28820052
    [Abstract] [Full Text] [Related]

  • 18. New quinoline derivatives as nicotinic receptor modulators.
    Manetti D, Bellucci C, Dei S, Teodori E, Varani K, Spirova E, Kudryavtsev D, Shelukhina I, Tsetlin V, Romanelli MN.
    Eur J Med Chem; 2016 Mar 03; 110():246-58. PubMed ID: 26840365
    [Abstract] [Full Text] [Related]

  • 19. Modulators of nicotinic acetylcholine receptors as analgesics.
    Jain KK.
    Curr Opin Investig Drugs; 2004 Jan 03; 5(1):76-81. PubMed ID: 14983978
    [Abstract] [Full Text] [Related]

  • 20. Nicotinic acetylcholine receptors in neuropathic and inflammatory pain.
    Hone AJ, McIntosh JM.
    FEBS Lett; 2018 Apr 03; 592(7):1045-1062. PubMed ID: 29030971
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.